Stocks · Health care · Services-Medical Laboratories

Labcorp

LH Clue Score34
United States Fiscal year ends December CIK 0000920148 Results filed 28 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Bryan T Vaughn
3 Nov 2026
EVP and President, Diagnostics
Sold on a plan
306
$353.70
$108.23K
Kerrii B Anderson
17 Aug 2026
Director
Sold on a plan
3,000
$318.02
$954.06K
Adam H Schechter
11 Aug 2026
President & CEO
Sold on a plan
4,669
$320.37
$1.50M
Bryan T Vaughn
2 Jul 2026
EVP and President, Diagnostics
Sold on a plan
234
$286.19
$66.97K
Kathryn W Kyle
2 Jul 2026
EVP, Chief Legal Officer
Sold on a plan
92
$286.19
$26.33K
Kathryn W Kyle
8 Jun 2026
EVP, Chief Legal Officer
Sold on a plan
762
$263.89
$201.08K
Adam H Schechter
11 May 2026
President & CEO
Sold on a plan
5,903
$254.50
$1.50M
Jonathan C Meltzer
27 Mar 2026
EVP, Operations
Sold on a plan
839
$267.05
$224.05K
Peter J Wilkinson
27 Mar 2026
SVP, Chief Accounting Officer
Sold on a plan
1,633
$267.05
$436.09K
Peter J Wilkinson
19 Feb 2026
SVP, Chief Accounting Officer
Sold on a plan
666
$277.94
$185.11K
Jonathan C Meltzer
12 Feb 2026
EVP, Operations
Sold on a plan
87
$290.42
$25.27K
Jonathan C Meltzer
10 Feb 2026
EVP, Operations
Sold on a plan
91
$276.79
$25.19K
Jonathan C Meltzer
9 Feb 2026
EVP, Operations
Sold on a plan
88
$275.53
$24.25K
Adam H Schechter
11 Nov 2025
President & CEO
Sold on a plan
5,745
$262.75
$1.51M

What was left out

Form 4 filings counted 89
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 3
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 200,650
History held since 4 Oct 2006